I sold with zero balance luckily, that was well dodgy. AIM lately is a very, very dodgy place. AIM casino, where companies lie throw rns's and get away with it with zero problems.
FinnCap, the company’s broker, has assessed the nascent potential of Evgen and come up with a 29p a share valuation (using a risk-adjusted discounted cash flow calculation) – some 20p more than the current share price.
Iam not really bothered because iam lth and no chance that i will sell my shares before 20, but take a look at the trades - 20k buys and 8.5 k sells and we are 1.05 % down. What is that all about??? Ive seen it here before few times as well.
In my opinion it’s just another quick wonga trader leaving. At the end of the day we don’t need them so the faster they move on the better for us really. GLA
My bet: 6.8 by Friday. Iam lth And iam waiting for 5 bags so it dont really matter 2 me. It’s one of the safest investments on the market. It’s nice that I don’t have to check RNS everyday at 7am :-)
RE: SFX-01 licensing deal for up to $160.5m21 Oct 2022 13:12
We have some top geniuses working for us. They seems capable of creating some amazing stuff. I bet it’s loud about them in pharmaceutical environment. Some huge corp might buy them out.
This share is the best ever for crisis: interest rates - dont affect us fuel prices - dont affect us energy prices - dont affect us Nothing affect us :-)